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Abstract
Background: In Australia, associations between geographic remoteness, socioeconomic disadvantage, and
colorectal cancer (CRC) survival show that survival rates are lowest among residents of geographically remote
regions and those living in disadvantaged areas. At present we know very little about the reasons for these
inequalities, hence our capacity to intervene to reduce the inequalities is limited.
Methods/Design: This study, the first of its type in Australia, examines the association between CRC survival and
key area- and individual-level factors. Specifically, we will use a multilevel framework to investigate the possible
determinants of area- and individual-level inequalities in CRC survival and quantify the relative contribution of
geographic remoteness, socioeconomic and demographic factors, disease stage, and access to diagnostic and
treatment services, to these inequalities. The multilevel analysis will be based on survival data relating to people
diagnosed with CRC in Queensland between 1996 and 2005 (n = 22,723) from the Queensland Cancer Registry
(QCR), area-level data from other data custodians such as the Australian Bureau of Statistics, and individual-level
data from the QCR (including extracting stage from pathology records) and Queensland Hospitals. For a subset of
this period (2003 and 2004) we will utilise more detailed, individual-level data (n = 1,966) covering a greater range
of risk factors from a concurrent research study. Geo-coding and spatial technology will be used to calculate road
travel distances from patients’ residence to treatment centres. The analyses will be conducted using a multilevel
Cox proportional hazards model with Level 1 comprising individual-level factors (e.g. occupation) and level 2 area-
level indicators of remoteness and area socioeconomic disadvantage.
Discussion: This study focuses on the health inequalities for rural and disadvantaged populations that have often
been documented but poorly understood, hence limiting our capacity to intervene. This study utilises and
develops emerging statistical and spatial technologies that can then be applied to other cancers and health
outcomes. The findings of this study will have direct implications for the targeting and resourcing of cancer control
programs designed to reduce the burden of colorectal cancer, and for the provision of diagnostic and treatment
services.
Background
Colorectal cancer is the second most commonly diag-
nosed invasive cancer in Australia, with 13,076 people
being diagnosed in 2005 (representing 13.0% of all new
cancer diagnoses) and 4,168 dying from the disease
(10.7% of all cancer deaths and 3.2% of all deaths) [1].
Australian incidence rates for colorectal cancer are
among the highest in the world [2] and it is the third
highest cancer contributor to health care expenditure in
Australia (estimated at about $235 million annually) [3].
Colorectal cancer is associated with considerable physi-
cal and psychological morbidity [4], due in part to the
side-effects of surgery, radiation, and systemic therapies.
While incidence rates are generally steady, numbers of
new colorectal cancer diagnoses have been increasing
with population growth [1].
Rural variations
Significant geographical variation in colorectal cancer
survival has been reported across Australia, with lower
survival estimates for people diagnosed outside major
cities [5-7], even when adjusted for spread of disease
[6,8]. Residents of rural areas of Queensland diagnosed
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with colorectal cancer have 5-year survival up to 14%
lower compared with those in the highly urbanised
south-east corner [5]. Similar inequalities have been
reported for other Australian states: when adjusted for
stage, there was up to a 30% increased excess mortality
risk from colon cancer within 5 years of diagnosis for
residents of more rural, less accessible areas in New
South Wales compared to highly accessible areas [6].
The reasons for rural inequalities in colorectal cancer
survival are complex and multi-faceted [9] and include
population and family age structure, socioeconomic sta-
tus, diet, ethnicity and Indigenous status, environmental,
industry and occupational exposures to carcinogens,
access to cancer screening and diagnostic services,
access to cancer treatment services, and level of co-mor-
bidities with other diseases such as cardiovascular dis-
ease and diabetes [10].
Since cancer stage is the most strongly predictive of
all clinical prognostic factors, it may be the most intui-
tive explanation for the rural inequalities in colorectal
cancer survival. Differences in stage have been shown to
be a key explanation for international differences in col-
orectal cancer survival [11]. In Australia however rural
inequalities in colorectal cancer survival have remained
even after adjusting for spread of disease [6]. While it
may be logical to suggest that rural people are diag-
nosed with more advanced cancers, a US study found
that the opposite was true, in that urban patients were
more likely to present with later stage colorectal cancer
than rural patients [12]. So although disease stage could
potentially explain a portion of the observed rural
inequalities in colorectal cancer survival, it is unlikely to
be the sole explanation.
Indigenous Australians comprise a larger proportion
of rural and remote areas than urban areas [13].
Although the incidence of colorectal cancer among Indi-
genous Australians has been reported to be substantially
lower than non-Indigenous Australians [14], compari-
sons of the mortality:incidence ratios suggest that once
diagnosed with colorectal cancer, Indigenous Australians
have poorer survival [14].
Location of and access to health services have been
recognised as important contributors to morbidity and
mortality in Australia. Health care services in Australia
are becoming increasingly centralised [15], with three
quarters of all radiation therapy facilities in Australia in
2002 being in capital cities [16]. There is merit in this
centralisation of oncology services; evidence suggests that
the best outcomes are obtained when patients are treated
by practitioners and institutions with high caseloads [17].
However this centralisation has implications for rural
cancer patients’ access to diagnostic and treatment ser-
vices, and the increased distances rural patients need to
travel to use those services that may a disincentive to
undertake or complete treatment regimens. This is parti-
cularly relevant when the treatment involves a series of
specific regimes, such as radiotherapy, that may involve
prolonged absence from home resulting in disruptions to
normal life and financial hardship [18].
Previous studies have shown that cancer patients in
rural and remote areas of Australia have reduced access
to cancer care services. These include fewer radical
prostatectomies for prostate cancer [19]; lower propor-
tions of breast-conserving surgery [20]; and a lower like-
lihood of completing radiotherapy treatment for rectal
cancer [21]. Despite national increases in the number of
general practitioners (GPs) per capita, numbers of GPs
have decreased in rural and remote areas [22]. Interna-
tionally, studies have demonstrated a direct association
between distance to cancer treatment services and
patients’ use of that treatment, with patients less likely
to access specialist treatment when longer distances are
involved [23-25].
Socio-economic variations
There continues to be a strong association between
socio-economic status (SES) and cancer survival interna-
tionally, with colorectal cancer survival rates typically
25%-35% lower among the most deprived populations
compared to the most affluent, even after adjustment
for spread of disease [26]. Reports from Australia [5,27]
suggest similar (but not significant) trends in colorectal
cancer survival by SES.
As is the case for rural inequalities, cancer stage is one
possible explanation for the socioeconomic inequalities
in colorectal cancer survival. International studies have
demonstrated that socio-economic inequalities reduced,
but still remained after adjustment for stage at diagnosis
[26]. While advanced stage at colorectal cancer diagno-
sis is generally more common among deprived people, it
is not always the case [26]. Therefore although disease
stage potentially explains some of the socioeconomic
survival inequalities in colorectal cancer (as with rural
inequalities), it can’t be assumed it will explain all, or
even most, of the differences.
While physical inactivity and obesity have been shown
to increase the risk of developing colorectal cancer, rela-
tively little is known about the risk factors for disease
progression and survival. However there is an emerging
body of evidence suggesting that higher intakes of Wes-
tern diets (including high amounts of red meat and fat)
[28], reduced physical activity [29], increased BMI [30],
smoking [31] and the presence of co-morbid conditions
[32] are associated with reduced survival for colorectal
cancer patients. If the prevalence of these risk factors dif-
fers according to SES, as has been suggested for physical
activity [33], then this could be one explanation for the
socioeconomic inequalities in colorectal cancer survival.
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There is increasing international evidence of colorectal
cancer patients in different socioeconomic groups being
given different treatment [26], with affluent colorectal
cancer patients in England being more likely to receive
surgery than disadvantaged patients [26]. In the United
States, people living in poorer areas and those without
private health insurance were less likely to receive
recommended adjuvant chemotherapy or radiotherapy
for stage II or III colon cancer [26]. The few Australian
studies [34] on this topic have suggested similar patterns
of reduced access to hospital services by colorectal can-
cer patients with lower socioeconomic status.
Limitations of previous studies
Current classifications of rurality [35] are typically based
on access to services. However they may be limited in
their specific application to cancer outcomes because
they do not place particular importance on access to
cancer-specific services. In Queensland (Australia) the
Area Remoteness Index of Australia [35] can classify
some areas as being less accessible than others even
though they are much closer to specialised cancer treat-
ment and tertiary hospital services. Due to the multifa-
ceted nature of rurality, it is important to measure the
independent effects of factors such as access to services
and distance to radiation treatment facilities, as well as
the Indigenous component. The sizeable Indigenous
populations in remote areas [13] and their poorer survi-
val from cancer compared to other Australians [14]
highlights the importance of separating the remoteness
and Indigenous effects.
In the same way, broad classifications are typically are
used to define socioeconomic status and assess socioeco-
nomic inequalities. People with low incomes may live in
very affluent areas, while the low socioeconomic areas
may include people with high individual incomes. This
lack of homogeneity with the SES areas may tend to dilute
any observed association between cancer survival and
socio-economic status [36]. As with rurality, the concept
of socio-economic status is multi-faceted, thus relying on
broad SES categories removes the opportunity to investi-
gate the separate components of socioeconomic status,
such as the independent effects of income or education.
This study will use a multilevel approach to investigate
the possible determinants of area- and individual-level
inequalities in colorectal cancer survival: and quantify
the relative contribution of geographic remoteness,
socioeconomic and demographic factors, disease stage,
and access to diagnostic and treatment services, to these
inequalities. It will thus overcome many of the metho-
dological and interpretive problems of standard ecologic
studies. By allowing for the partitioning and modelling
of complex sources of area- and individual-level
variation we will be able to determine whether areas
have an impact on colorectal cancer survival indepen-
dently of the characteristics of people who live in the
areas. Without this information it is likely that our abil-
ity to address the inequalities in colorectal cancer survi-
val will continue to be compromised.
Study Aims
1. To quantify the extent of area-level variation in color-
ectal cancer survival among patients diagnosed in
Queensland between 1996 and 2005
2. To assess the extent to which area-level variation in
colorectal cancer survival is due to individual-level fac-
tors (i.e. patient characteristics, disease stage, co-mor-
bidity, and access to health care and treatment services);
and to examine the independent contribution of these
individual-level factors to colorectal cancer survival.
3. To assess the extent to which area-level variation in
colorectal cancer survival is associated with geographic
remoteness and area socioeconomic disadvantage, after
adjustment for individual-level factors.
4. To determine whether the relationship between indi-
vidual-level factors and colorectal cancer survival differs
by extent of geographic remoteness and area socioeco-
nomic disadvantage.
Methods/Design
Funding and Support
This project was awarded funding by the (Australia)
National Health and Medical Research Council (ID:
561700). Cancer Council Queensland provided addi-
tional funding for the maintenance of the GIS software.
Ethical Clearance
This project was awarded ethical clearance by the Beha-
vioural and Social Sciences Ethical Review Committee at
the University of Queensland (Project No. 2008002041).
Additional clearance to access confidential health infor-
mation was obtained from the Research Ethics and Gov-
ernance Unit, Queensland Health.
Study Design
This study is a cross-sectional multi-level study
(1996-2007)
Setting
This study is being conducted using data relating to
people diagnosed with colorectal cancer in Queensland
(Australia) between 1996 and 2007 (inclusive). Queens-
land is the second largest state by area in Australia, and
the third largest by population (4.4 million in 2009). It
has the most decentralised population of any of the
Australian states [37].
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Study areas
Three spatial units comprising the Australian Standard
Geographical Classification (ASGC) will be used within
Queensland - statistical divisions (SD), statistical subdi-
visions (SSD), and statistical local areas (SLA). These
units cover Queensland without gaps or overlap. The
SLAs, often based on the incorporated bodies of local
governments who are responsible for service provision
and infrastructure at the local and regional level, will be
the primary focus for the area-level analysis. In 2006
there were 478 SLAs in Queensland with a median
population of 5810 (range: 7 to 77523). The SLA is also
used as the standard geographical area definition by
most relevant data providers, in particular the QCR and
Australian Bureau of Statistics. To account for SLA
boundary changes over time we have applied a concor-
dance developed and purchased from the Australian
Bureau of Statistics to convert all SLA boundaries to the
2006 ASGC definition.
Study participants
Details on all 22,723 colorectal cancer patients diag-
nosed in Queensland over the 10 year period between
1st January 1996 and 31st December 2005 were obtained
from the Queensland Cancer Registry (QCR) via
approved processes. Notification of cancer is a statutory
requirement for all public and private hospitals, nursing
homes and pathology services. Queensland pathology
laboratories provide copies of pathology reports for can-
cer specimens to the QCR. The QCR also records
details of SLA at diagnosis, as well as full address at last
notification for geocoding purposes.
A separate longitudinal study of 1966 Queensland
residents diagnosed with colorectal cancer between 2003
and 2004 while aged between 20 and 80 years has been
conducted [38] by the Cancer Council Queensland, the
cohort of which will be used for this study.
Sample size and power calculations
Detailed power calculations require specific estimates of
the variation in colorectal cancer survival between and
within area units. Since the quantification of this varia-
tion is the primary goal of this study, and the number
of records available to use are fixed, our retrospective
power calculations (using Optimum Design software
[39]) are based solely on the approximate number of
clusters and records per cluster.
The average 5-year cause-specific survival for colorec-
tal cancer patients in Queensland between 1996 and
2002 ranged from 56% for urban affluent to 50% in
rural areas (unpublished data, Queensland Cancer Regis-
try). There were 22,723 people diagnosed with colorectal
cancer in Queensland between 1996 and 2005. This
colorectal cancer cohort covers all 479 SLAs with
between 1 and 416 (mean = 47, median = 28) patients
in each SLA. Using a binomial approximation, and
assuming 479 clusters with an average of 42 records per
cluster and a baseline survival proportion of 50%, this
gives 85% power at 0.05% significance to detect a differ-
ence in survival proportions of 2%.
The sub-study of 1,966 respondents to the longitudi-
nal study between 2003 and 2004 covered 376 SLAs
with between 1 and 46 (mean 5.2, median = 4) respon-
dents in each SLA. By combining SLAs with similar rur-
ality and socioeconomic characteristics, and so assuming
100 clusters with an average of 20 records per cluster
and a baseline survival proportion of 50%, this gives
80% power at 0.05% significance to detect a difference
in survival proportions of 6.5%.
Data collection
Area-level data
Location of cancer treatment centres
The caseload of CRC-related surgical procedures in
Queensland public and private hospitals since the 1995/
96 financial year will be obtained from the Queensland
Hospital Admitted Patient Data Collection (QHAPDC),
which contains information of all surgical episodes of
care for patients admitted to Queensland public and pri-
vate hospitals. Treating hospitals will be categorised into
high volume and low volume based on the hospital-spe-
cific number of patients who had a colorectal cancer-
related surgical procedure, a method demonstrated pre-
viously for breast cancer [40]. Additional details about
the presence of multidisciplinary teams, chemotherapy
and radiotherapy services in specific hospitals since
1996 will be obtained through relevant publications [16]
and discussions with oncology clinicians and other
health professionals. This will be supplemented by
unstructured telephone surveys of oncology nurses and
clinicians in Queensland hospitals, most of which have
already been completed. Full street address information
is available for all public and private hospitals.
Socioeconomic indicators
Information about education levels, household income,
types of occupation, median mortgage and rental pay-
ments and other socioeconomic indicators for each SLA
will be obtained from the census data files released by
the Australian Bureau of Statistics for 1996, 2001 and
2006. We will also use the ABS SEIFA index of economic
disadvantage, which is based on the percentage of people
in the SLA with low income, low educational attainment
or who are unemployed or employed in relatively
unskilled occupations (among others). While acknowled-
ging the weaknesses of this index [41], we will assess the
impact this index has on measured socioeconomic
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inequalities compared to the more detailed information.
Standard interpolation methods will be used to estimate
these values in intervening years.
Life expectancy
The statistical modeling in this study utilizes cause-spe-
cific survival. An adjustment will be made for underlying
mortality to account for general mortality differentials.
Average life expectancy will be calculated from the unit
record mortality file for Queensland from the Australian
Bureau of Statistics that contains details of all-cause
mortality by SLA.
Remoteness
Standard measures of remoteness classifications [35],
and derived measures based on distances from major
centres will be used, in addition to new SLA-based clas-
sifications based on distance to cancer treatment
facilities.
Individual level variables
Stage at diagnosis
The interpretation of differences in cancer survival esti-
mates between population subgroups requires accurate
information on cancer stage [11]. Since clinical stage is
not routinely collected by population-based cancer regis-
tries in Australia, including the QCR, options include
resource intensive medical chart reviews, or sourcing
from pathology reports. Colorectal cancer is one of the
most amenable to extracting stage from pathology
reports, with the main limitation being a lack of informa-
tion about metastasis [42]. Our recent study in Queens-
land, using data from a longitudinal study of colorectal
cancer patients reported 80% agreement between stage
extracted from pathology reports and stage obtained
from clinical specialists [43]. This agreement increased to
95% when collapsing stage to A/B and C/D. We expect
that approximately 85% of records will have sufficient
information to assess stage, similar to that reported in
the SEER registries (86%) [44] and in New South Wales
(82%) [45]. Validity checks of test-retest reliability, inter-
rater reliability, and agreement with clinical specialists
[43]) will be conducted for a subset of the pathology
records to maintain the accuracy of stage extraction.
Personal demographic information
The QCR collects information on date of diagnosis, place
of usual residence at diagnosis, age group at diagnosis, sex,
country of birth, marital status and occupation. Occupa-
tion is a mandatory data item, with 86% of colorectal can-
cer patients diagnosed in Queensland between 1996 and
2005 having a known occupation recorded, while 98% had
a known marital status recorded (personal communica-
tion, Queensland Cancer Registry).
Indigenous status
The QCR collects data on the Indigenous status of peo-
ple diagnosed with cancer in Queensland, and these
data are available for the whole study period. Between
1996 and 2005 92% of colorectal cancer patients diag-
nosed in Queensland had a known Indigenous status
recorded (personal communication, Queensland Cancer
Registry). Although there is evidence of some under-
identification, the Indigenous identifier in Queensland is
considered to have good coverage [46].
Mortality
Deaths among the colorectal cancer cohort are routinely
identified by the QCR by matching patient information
to the Office of the Queensland Registrar of Births,
Deaths and Marriages and to the National Death Index
at the Australian Institute of Health and Welfare. Can-
cer registries in other states and territories also provide
information on interstate deaths. People who were not
known to have died are assumed to be still alive. Each
member of the colorectal cancer study cohort will have
at least two years of potential mortality follow-up to 31st
December 2007.
Location where surgical treatment received
By utilising a deterministic link between the QHAPDC
and the QCR (based on treatment facility and hospital
unit record number) we can identify at which specific
hospital each colorectal cancer patient actually received
surgical treatment. This process has already been suc-
cessfully utilised for a patterns of care study [40].
Co-morbidities
Utilising the linkage between the QCR and QHAPDC
described earlier, co-morbidities from each patient epi-
sode will be identified based on principal or other diag-
nosis codes (ICD-9-AM and ICD-10-AM classifications).
While these diagnosis codes are limited to those condi-
tions that specifically affected the inpatient’s manage-
ment in terms of treatment, diagnostic procedures or
monitoring, they will provide information about impor-
tant co-morbidites such as diabetes and cardiovascular
disease.
Cancer treatment information
Information is available from the colorectal cancer long-
itudinal study [38] regarding the details of surgical treat-
ment, chemotherapy and radiation therapy that the
patients received, including geographical location details.
Detailed demographic and risk factor data
The colorectal cancer longitudinal study [38] provides
information about the diagnostic process, quality of life,
behavioural risk factors such as physical activity and
body mass index, along with detailed demographic infor-
mation. Survival information will also be available.
Distance calculations
All address details for colorectal cancer patients, treat-
ment facilities and diagnostic services will be geocoded
using MapInfo MapMaker®, a commercial package
designed to clean and convert address information into
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latitude and longitude coordinates. When full street
address information is available, this will be used for
geo-coding purposes. When full street address informa-
tion is not available the centroid of the SLA will be
used. In 1998 approximately 84% of colorectal cancer
patients had full street address information, which
increased to 93% in 2004 (personal communication,
Queensland Cancer Registry).
Distances between patients, treatment facilities and
other centres will be calculated directly from the geo-
coded latitude and longitude points. Initially distance
will be measured in terms of straight line “as the crow
flies”, as have other international studies [23-25]. How-
ever since the method can underestimate travel times
[24] we will also calculate distance according to road
travel distance and road travelling time. These road dis-
tances will be calculated using MapInfo Professional®,
combined with street network analysis and display tools.
A custom application has been developed by MapInfo to
calculate the closest road travel distance between one
location (such as patient’s residence) and multiple loca-
tions (such as various treatment facilities).
Analyses
Multilevel perspective
Previous Australian studies examining area variation in
colorectal cancer survival have used an aggregate ecolo-
gic design [5,27]. The conceptual and statistical problems
with these designs have been well documented [47]. Eco-
logic studies that use data aggregated to a single geo-
graphic scale cannot provide a quantification of the
variation between areas in terms of their survival profiles,
and then, more importantly, indicate whether the varia-
tion is likely due to the clustering of individuals (i.e. a
composition effect) or the environmental characteristics
of the areas (i.e. a context effect). Thus, even though pre-
vious Australian studies find lower survival times in geo-
graphically remote and socioeconomically disadvantaged
areas, this does not mean that areas per se are important
in terms of influencing the survival probability of the
area’s residents. Ecologic studies leave open the possibi-
lity that area variation in survival is an artefact of varying
population compositions, and unless these are taken into
account (which aggregate studies cannot do), area- and
individual-level sources of variation remain confounded.
It therefore remains an unanswered question as to
whether geographically remote and socioeconomically
disadvantaged areas are important determinants of color-
ectal cancer survival in Australia.
Survival analyses
The survival analysis will focus on cause-specific survival
for all colorectal cancer patients diagnosed in Queens-
land between 1996 and 2005, with a minimum follow-
up of two years to 31st December 2007. Cause-specific
survival will be used, since relative survival has been
suggested to under-estimate social inequalities [48]. The
QCR, like most other Australian registries, codes the
cause of death using information from the ABS mortal-
ity file, pathology laboratories and other cancer-specific
data sources, increasing the accuracy in the cause of
death codes. Patients who died of causes other than
CRC, or were still alive as at 31st December 2007 will be
censored. Survival time will be measured as the number
of days from date of diagnosis to date of death, or the
censoring date, whichever comes first.
Multilevel models
The multilevel analyses will be conducted using a multi-
level Cox proportional hazards model [49] with Level 1
comprising the individual-level factors (such as risk fac-
tors) and level 2 the indicators of geographic remoteness
and area socioeconomic disadvantage. This approach
extends traditional (single-level) proportional hazards
modelling by incorporating a random intercept that
reflects the average survival outcome (time or probabil-
ity) for each area. The analyses will be undertaken in
Mlwin 2.15 with the Cox survival macro, and the mod-
els will be estimated using the iterative generalised least
squares algorithm (Poisson first order marginal quasi-
likelihood).
The study’s objectives will be addressed using a four-
stage modelling strategy:
Model 1: (Objective 1): First, a null (intercept only)
model will be specified to quantify the extent of area-
level variation (i.e. variation between SLA) in colorectal
cancer survival
Model 2: (Objective 2): Extends Model 1 by including
individual-level factors (patient characteristics, disease
stage, co-morbidity, and access to health care and treat-
ment services) as fixed effects. This will tell us how
much of the area-variation in colorectal cancer survival
is due to these compositional factors; and also assess the
contribution of each individual-level factor to survival.
Model 3: (Objective 3): Extends Model 2 by including
the measures of geographic remoteness and area socioe-
conomic disadvantage as fixed effects. This will show us
how much of the area-variation in colorectal cancer sur-
vival is due to these factors (independent of individual-
level factors). This model will also assess the associa-
tions between geographic remoteness, area disadvantage
and survival.
Model 4: (Objective 4): In this model we specify cross-
level interactions between the individual-level factors
and geographic remoteness and area disadvantage. This
analysis will tell us if the relationship between colorectal
cancer survival and each of the individual-level factors
differs as a function of geographic remoteness or area
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disadvantage. For example, if the association between
occupation and colorectal cancer survival is the same in
both geographically remote and accessible areas, and
affluent and deprived areas.
Discussion
Colorectal cancer is the most commonly diagnosed can-
cer in Australia. The health inequalities for rural and
disadvantaged populations are often documented but
continue to widen. Our capacity to intervene is cur-
rently limited because very little is known about the rea-
sons for the inequalities in colorectal cancer survival.
The results from this study will inform our understand-
ing of the causes of inequalities in colorectal cancer sur-
vival that can be addressed through improvements in
health policy and practice aimed at improving popula-
tion health and reducing inequalities that result from
geographic remoteness and area disadvantage.
To our knowledge this study will be the first of its
kind in Australia to investigate key area-level and indivi-
dual-level components of colorectal cancer survival after
adjusting for spread of disease, using a multilevel analy-
tical approach on a combination of routine population-
based data, longitudinal research data and original data
on cancer stage, and applying emerging statistical and
spatial technology.
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